As employers look for solutions to attract and retain a stable workforce, many are shifting their drug-free workplace stance from zero tolerance to one that supports people in recovery from substance use disorder (SUD). With this shift comes the need for businesses to broaden their perspectives and practices to support the unique needs of those in recovery. This includes the use of prescription medications to boost recovery outcomes – referred to as medication-assisted treatment (MAT). Despite MAT’s proven effectiveness, particularly in the treatment of opioid use disorder, many employers remain confused (and even skeptical) about how to respond to an employee’s use of these prescribed medications.
